TRLV
TRLV
Trulieve Cannabis Corp.Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q1-2026 | $286.75M ▼ | $134.64M ▼ | $2.41M ▲ | 0.84% ▲ | $0.01 ▲ | $82.27M ▲ |
| Q4-2025 | $293.15M ▲ | $155.73M ▲ | $-42.9M ▼ | -14.63% ▼ | $-0.22 ▼ | $61.29M ▼ |
| Q3-2025 | $288.19M ▼ | $128.47M ▼ | $-26.84M ▼ | -9.31% ▼ | $-0.14 ▼ | $88.79M ▼ |
| Q2-2025 | $302.09M | $130.54M | $-13.78M | -4.56% | $-0.07 | $98.45M |
What's going well?
The company made a strong recovery by slashing expenses, boosting operating profits, and returning to profitability. Operating efficiency improved, and the business is now generating cash from its core operations.
What's concerning?
Revenue is slipping and net profit margins are razor-thin. High taxes and interest costs are eating into profits, and share dilution is a concern for investors.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q1-2026 | $352.88M ▲ | $2.78B ▲ | $1.63B ▲ | $1.17B ▲ |
| Q4-2025 | $255.53M ▼ | $2.7B ▼ | $1.55B ▼ | $1.16B ▼ |
| Q3-2025 | $449.2M ▲ | $2.94B ▲ | $1.76B ▲ | $1.2B ▼ |
| Q2-2025 | $392.58M | $2.92B | $1.71B | $1.23B |
What's financially strong about this company?
The company has a large cash cushion, very strong liquidity, and a healthy equity base. Most debt is long-term, so there’s no immediate repayment pressure.
What are the financial risks or weaknesses?
Debt is rising, and nearly half of the assets are intangible, which could be risky if acquisitions don’t perform. Retained earnings are deeply negative, showing a history of losses.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q1-2026 | $2.28M ▲ | $55.71M ▼ | $-13.19M ▼ | $54.83M ▲ | $97.34M ▲ | $42.22M ▼ |
| Q4-2025 | $-43.59M ▼ | $59.22M ▼ | $-5.89M ▲ | $-255.39M ▼ | $-202.07M ▼ | $52.23M ▼ |
| Q3-2025 | $-28.78M ▼ | $76.77M ▼ | $-15.38M ▼ | $-4.77M ▲ | $56.62M ▼ | $60.26M ▼ |
| Q2-2025 | $-16.11M | $85.7M | $-8.24M | $-5.83M | $71.63M | $69.48M |
What's strong about this company's cash flow?
The company consistently generates real cash from its operations and swung from a big loss to a small profit. Cash flow quality is high, with most reported profit converting to cash, and the cash balance is strong.
What are the cash flow concerns?
Free cash flow is down due to higher capital spending, and the company took on new debt after paying down a lot last quarter. Working capital moves (like inventory build and lower payables) may not be sustainable.
5-Year Trend Analysis
A comprehensive look at Trulieve Cannabis Corp.'s financial evolution and strategic trajectory over the past five years.
Key strengths include a sizable revenue base with strong gross margins, positive operating and cash earnings, and a very solid liquidity profile. The company has a robust asset base supported by meaningful equity, and it is actively deleveraging. Operationally, Trulieve benefits from vertical integration, a focused hub strategy in core states, and a differentiated portfolio of brands and products powered by advanced cultivation and extraction capabilities and strong data use.
Main risks relate to profitability, balance sheet composition, and the broader industry environment. The company currently posts net losses, driven by heavy overhead, interest, and tax burdens, and carries large negative retained earnings. A significant portion of assets is tied up in goodwill and other intangibles that could be vulnerable to impairment if acquisitions underperform. Industry‑wide factors—including regulatory uncertainty, restrictive tax treatment, pricing pressure, and intense competition—add further uncertainty to future earnings and cash flows.
Taken together, Trulieve appears to be a scaled operator with solid operational fundamentals and cash generation, but still in transition from growth‑and‑acquire mode to a more disciplined, profit‑focused phase. If management can continue to control costs, optimize its tax and financing structure, and keep leveraging its innovation and hub strategy, the business has a path toward stronger, more sustainable profitability. However, this path is not guaranteed; it depends on execution in a volatile regulatory environment and on the company’s ability to maintain differentiation and financial discipline in a rapidly evolving cannabis market.
About Trulieve Cannabis Corp.
http://www.trulieve.comTrulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q1-2026 | $286.75M ▼ | $134.64M ▼ | $2.41M ▲ | 0.84% ▲ | $0.01 ▲ | $82.27M ▲ |
| Q4-2025 | $293.15M ▲ | $155.73M ▲ | $-42.9M ▼ | -14.63% ▼ | $-0.22 ▼ | $61.29M ▼ |
| Q3-2025 | $288.19M ▼ | $128.47M ▼ | $-26.84M ▼ | -9.31% ▼ | $-0.14 ▼ | $88.79M ▼ |
| Q2-2025 | $302.09M | $130.54M | $-13.78M | -4.56% | $-0.07 | $98.45M |
What's going well?
The company made a strong recovery by slashing expenses, boosting operating profits, and returning to profitability. Operating efficiency improved, and the business is now generating cash from its core operations.
What's concerning?
Revenue is slipping and net profit margins are razor-thin. High taxes and interest costs are eating into profits, and share dilution is a concern for investors.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q1-2026 | $352.88M ▲ | $2.78B ▲ | $1.63B ▲ | $1.17B ▲ |
| Q4-2025 | $255.53M ▼ | $2.7B ▼ | $1.55B ▼ | $1.16B ▼ |
| Q3-2025 | $449.2M ▲ | $2.94B ▲ | $1.76B ▲ | $1.2B ▼ |
| Q2-2025 | $392.58M | $2.92B | $1.71B | $1.23B |
What's financially strong about this company?
The company has a large cash cushion, very strong liquidity, and a healthy equity base. Most debt is long-term, so there’s no immediate repayment pressure.
What are the financial risks or weaknesses?
Debt is rising, and nearly half of the assets are intangible, which could be risky if acquisitions don’t perform. Retained earnings are deeply negative, showing a history of losses.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q1-2026 | $2.28M ▲ | $55.71M ▼ | $-13.19M ▼ | $54.83M ▲ | $97.34M ▲ | $42.22M ▼ |
| Q4-2025 | $-43.59M ▼ | $59.22M ▼ | $-5.89M ▲ | $-255.39M ▼ | $-202.07M ▼ | $52.23M ▼ |
| Q3-2025 | $-28.78M ▼ | $76.77M ▼ | $-15.38M ▼ | $-4.77M ▲ | $56.62M ▼ | $60.26M ▼ |
| Q2-2025 | $-16.11M | $85.7M | $-8.24M | $-5.83M | $71.63M | $69.48M |
What's strong about this company's cash flow?
The company consistently generates real cash from its operations and swung from a big loss to a small profit. Cash flow quality is high, with most reported profit converting to cash, and the cash balance is strong.
What are the cash flow concerns?
Free cash flow is down due to higher capital spending, and the company took on new debt after paying down a lot last quarter. Working capital moves (like inventory build and lower payables) may not be sustainable.
5-Year Trend Analysis
A comprehensive look at Trulieve Cannabis Corp.'s financial evolution and strategic trajectory over the past five years.
Key strengths include a sizable revenue base with strong gross margins, positive operating and cash earnings, and a very solid liquidity profile. The company has a robust asset base supported by meaningful equity, and it is actively deleveraging. Operationally, Trulieve benefits from vertical integration, a focused hub strategy in core states, and a differentiated portfolio of brands and products powered by advanced cultivation and extraction capabilities and strong data use.
Main risks relate to profitability, balance sheet composition, and the broader industry environment. The company currently posts net losses, driven by heavy overhead, interest, and tax burdens, and carries large negative retained earnings. A significant portion of assets is tied up in goodwill and other intangibles that could be vulnerable to impairment if acquisitions underperform. Industry‑wide factors—including regulatory uncertainty, restrictive tax treatment, pricing pressure, and intense competition—add further uncertainty to future earnings and cash flows.
Taken together, Trulieve appears to be a scaled operator with solid operational fundamentals and cash generation, but still in transition from growth‑and‑acquire mode to a more disciplined, profit‑focused phase. If management can continue to control costs, optimize its tax and financing structure, and keep leveraging its innovation and hub strategy, the business has a path toward stronger, more sustainable profitability. However, this path is not guaranteed; it depends on execution in a volatile regulatory environment and on the company’s ability to maintain differentiation and financial discipline in a rapidly evolving cannabis market.

CEO
Kimberly A. Rivers
Compensation Summary
(Year )
Upcoming Earnings
ETFs Holding This Stock
Summary
Showing Top 1 of 2
Ratings Snapshot
Rating : C+

